ISIS-5132

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameISIS-5132
Drug Alias NameODN-698ISIS-5132CGP-69846A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionC-Raf kinase inhibitors
TargetsC-Raf kinase
Therapy Area/IndicationsProstatic NeoplasmsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals IncNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[8] 

Other Information

ATC CodeN/A
Related LinksN/A